Assistant Professor of Medicine
University of Chicago
Daniel Catenacci, MD is an adult GI medical oncologist and associate director of the gastrointestinal oncology program at the University of Chicago, specializing in the treatment of gastroesophageal cancers.
An active basic and clinical researcher, Dr. Catenacci is involved in bench-to-bedside translational research with an overarching goal to validate and improve personalized treatment, immunotherapy, and precision medicine for gastroesophageal cancer and other GI cancers. A major focus of his research is on the quantification of tumor molecular heterogeneity both between individuals with gastroesophageal cancer, but importantly also within a given individual within one tumor site, and from one tumor site to another, and how this impacts personalized targeted therapeutic approaches. Additionally, Dr. Catenacci designs and executes novel clinical trials to implement treatment strategies based on these laboratory findings and discoveries.